Compass (COMP) stock: $850 million note deal priced as Anywhere merger close nears
8 January 2026
1 min read

Compass (COMP) stock: $850 million note deal priced as Anywhere merger close nears

New York, Jan 8, 2026, 09:02 EST — Premarket

Compass, Inc. said on Thursday it priced an upsized $850 million offering of convertible senior notes due 2031, lining up fresh financing as it heads into the final stretch of its planned tie-up with rival Anywhere Real Estate. The shares ended Wednesday up 9.4% at $11.84. 1

Compass and Anywhere said stockholders at both companies backed the merger at special meetings on Wednesday, and the companies expect to close the deal on Jan. 9. “We are pleased with the strong support from our and Anywhere’s stockholders,” Compass founder and CEO Robert Reffkin said in a joint statement. 2

Convertible notes are debt that can later convert into stock, which can dilute existing holders if the shares rise. Compass said the notes will pay 0.25% interest and convert at about $15.98 a share — a roughly 35% premium to the Jan. 7 close — and it arranged “capped call” option trades to soften dilution up to an initial cap price of $23.68. It plans to use proceeds for general corporate purposes, including paying down some Anywhere debt and merger costs, and said the offering is expected to settle on or about Jan. 9. 3

The note pricing lands on top of a busy set of filings a day earlier. Compass raised its fourth-quarter outlook and said it expects revenue at the high end of its prior range of $1.59 billion to $1.69 billion, with adjusted EBITDA — a profit measure that strips out some costs — at or slightly above the high end of $35 million to $49 million. It also said the Hart-Scott-Rodino antitrust waiting period for the merger expired on Jan. 2 and that it plans to terminate remaining commitments under a $750 million bridge financing arrangement after completing the notes offering. 4

That mix matters now because investors are trying to handicap the combined company’s balance sheet before the next earnings season rolls around, while the U.S. housing market stays tied to mortgage rates and transaction volume. Brokerages can gain share fast in a hot market, then scramble when listings thin out.

Compass’ planned combination with Anywhere would create one of the largest U.S. residential brokerage networks by sales volume, out-sizing rivals such as eXp World Holdings’ eXp Realty, Barron’s reported, citing industry data. Barron’s said the two firms booked about $418 billion in 2024 sales volume. 5

But the setup carries obvious risks. Compass flagged that both the note sale and the merger remain subject to closing conditions, and the financing can still be derailed by market swings. The deal has also drawn political scrutiny, with U.S. Senators Elizabeth Warren and Ron Wyden urging antitrust regulators in December to investigate the tie-up, saying it could hurt homebuyers. 6

Stock Market Today

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
New York, Feb 7, 2026, 09:39 EST — Market closed. Apple Inc (AAPL.O) shares ended Friday up 0.8% at $278.12 after swinging between $276.92 and $280.90, before dipping 0.3% in after-hours trading. U.S. markets are shut on Saturday, but the stock goes into Monday with a familiar question back on the tape: will Apple raise iPhone prices, or eat higher costs. 1 The immediate pressure point is memory. A tightening supply of DRAM — the memory chips that help phones run power-hungry apps smoothly — is pushing up component costs just as investors are re-pricing the economics of the broader
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
American Airlines stock (AAL) slips premarket as free Wi‑Fi plan lands and earnings near
Previous Story

American Airlines stock (AAL) slips premarket as free Wi‑Fi plan lands and earnings near

Intel stock jumps in premarket as 18A ramp talk keeps the turnaround trade hot
Next Story

Intel stock jumps in premarket as 18A ramp talk keeps the turnaround trade hot

Go toTop